ODRP Pharma SRL
1.0 FTEODRP Pharma reported total assets of €2.24m at the end of the 2025 financial year (annual accounts filed with the NBB on 12 May 2026), with 1 full-time equivalent.
The score of ODRP Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -38 % Total assets -33 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ODRP Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 May 2026
- Year ended 31 Dec 2024filed on 16 Jun 2025
- Year ended 31 Dec 2023filed on 11 Jun 2024
- Year ended 31 Dec 2022filed on 09 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
ODRP Pharma's financial analysis
- Solvency87.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ODRP Pharma
ODRP Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0462.507.084
- VAT number
- BE0462507084
- Peppol
- Registered · 0208:0462507084 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Jan 1998
- Registered office
- 9041 Ghent
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 12 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
ODRP Pharma (SRL) has been based in Ghent since 1998, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 70,773 € and equity of €1.97m; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 87.7%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to ODRP Pharma
Companies in the same business, of comparable size and area, outside its group.
- ANAP Retail sale of pharmaceutical products Aalst · balance sheet €1.37m
- Apovsk Retail sale of pharmaceutical products Kortrijk · balance sheet €2.26m
- Armatilco Retail sale of pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet €3.44m
- Apotheek Schellekens - Lauwers Retail sale of pharmaceutical products Schelle · balance sheet €1.84m
- APR.P.D. Retail sale of pharmaceutical products Hasselt · balance sheet €2.05m
- Varmaca Retail sale of pharmaceutical products Peer · balance sheet €2.03m
- Pharmacie Squelard Retail sale of pharmaceutical products Walcourt · balance sheet 819,721 €
- Thomas Broos Retail sale of pharmaceutical products Herent · balance sheet €1.19m
Frequently asked questions about ODRP Pharma
What is the revenue of ODRP Pharma?
ODRP Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ODRP Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0462507084 for ODRP Pharma, if the company is VAT-registered. Its company number (CBE) is 0462.507.084.
Where is the registered office of ODRP Pharma?
According to the CBE register, the registered office of ODRP Pharma is in 9041 Ghent.
What is the equity of ODRP Pharma?
At the close of the 2025 financial year, the equity of ODRP Pharma amounts to 1,968,918 €, a solvency of 87.7% of total assets.
How many people work at ODRP Pharma?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages ODRP Pharma?
The register lists 5 active mandates at ODRP Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ODRP Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →